Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anna N. Petrova
Observed names:
A. N. Petrova,
Anna Petrova,
Anna Petrová
Institution:
National Medical Research Center for Hematology
Observed institutions:
Rabin Medical Center,
National Medical Research Center for Hematology,
Ministry of Health of the Russian Federation,
Versiti Blood Research Institute Foundation,
All India Institute of Medical Sciences
ORCID:
0009-0001-6809-4328
Observed ORCID:
0009-0001-6809-4328
OpenAlex ID:
A5110345735
PF-114: A 4th Generation Tyrosine Kinase-Inhibitor for Chronic Phase Chronic Myeloid Leukaemia Including BCRABL1T315I
2019
·
Anna G. Turkina
, Olga Vinogradova
, et al.
·
Blood
·
20
Phase-1 Study of PF-114 Mesylate in CML Failing Prior Tyrosine Kinase-Inhibitor Therapy
2018
·
Anna G Turkina
, Olga Vinogradova
, et al.
·
Blood
·
15
PF-114 in Patients Failing Prior Tyrosine Kinase-Inhibitor Therapy Including BCR::ABL1T315I
2021
·
Anna G. Turkina
, Olga Vinogradova
, et al.
·
Blood
·
9
The First Results of Asciminib Therapy in Highly Pretreated Chronic Myeloid Leukemia Patients Under the Managed Access Program (MAP) in Russian Federation
2021
·
Anna G. Turkina
, Oleg A. Shukhov
, et al.
·
Blood
·
6
The Updated Results of Asciminib Managed-Access Program (MAP) in Patients with Chronic Myeloid Leukemia in Russia
2023
·
Elena Kuzmina
, Ekaterina Chelysheva
, et al.
·
Blood
·
5
PF-114 Mesylate, a Novel Third Generation ATP-Competitive BCR-ABL Tyrosine Kinase Inhibitor: First Safety and Efficacy Data from a Phase I Study in Patients with CML with Failure of Prior TKI Therapy
2017
·
Anna G Turkina
, Oleg Shukhov
, et al.
·
Blood
·
5
Two-Year Updated Results of Asciminib Managed-Access Program (MAP) in Russia
2022
·
Anna Turkina
, Elena A. Kuzmina
, et al.
·
Blood
·
4
Treatment-free remission in patients with chronic myeloid leukemia: literature review
2019
·
A. N. Petrova
, E. Yu. Chelysheva
, et al.
·
Oncohematology
·
3
PDF
Quality of Life in Chronic Myeloid Leukemia Patients with Deep Molecular Response Who Stopped Therapy By Tyrosine Kinase Inhibitors: Interim Results of Russian Prospective Multicenter Trial RU-SKI
2018
·
Anna Petrova
, Ekaterina Chelysheva
, et al.
·
Blood
·
2
Treatment of Patients with Chronic Myeloid Leukemia During Pregnancy According to Scheme Considering the Leukemic Burden and Term of Pregnancy (the LRT Scheme)
2018
·
Ekaterina Chelysheva
, Anna Turkina
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
Results of the Molecular Response Evaluation and TKI Dose Adjustment in Chronic Myeloid Leukemia Patients in Prospective Study of Reduction and Discontinuation Treatment of TKI (READIT)
2024
·
Oleg Shukhov
, Margarita Gurianova
, et al.
·
Blood
·
1
P673: Asciminib Managment in Chronic Myeloid Leukemia (cml) Patients With T315i Mutation.
2023
·
Elena Kuzmina
, Elza Lomaia
, et al.
·
HemaSphere
·
1
Humoral Immunity and Adverse Events after Vaccination Against COVID-19 By a Vector Based Vaccine Sputnik V in Patients with Chronic Myeloid Leukemia
2021
·
Ekaterina Yu. Chelysheva
, Anna Petrova
, et al.
·
Blood
·
1
PDF
The Role of BCR-ABL Levels Fluctuations and Loss of Deep Molecular Response after Treatment Discontinuation in Patients with Chronic Myeloid Leukemia in the Prospective Trial RU-SKI
2020
·
Anna Petrova
, Ekaterina Yu. Chelysheva
, et al.
·
Blood
·
1
Genetic markers of stable molecular remission in chronic myeloid leukemia after targeted therapy discontinuation
2018
·
Svetlana A. Smirnikhina
, Ekaterina Yu. Chelysheva
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
1
POSTER: CML-254 Asciminib Management in Chronic Myeloid Leukemia (CML) Patients With T315I Mutation
2023
·
Elena Kuzmina
, Elza Lomaia
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
POSTER: CML-250 The Prognostic Factors of Late Molecular Relapses after Treatment Discontinuation in Patients With Chronic Myeloid Leukemia
2023
·
Anna Petrova
, Oleg Shukhov
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CML-250 The Prognostic Factors of Late Molecular Relapses after Treatment Discontinuation in Patients With Chronic Myeloid Leukemia
2023
·
Anna Petrova
, Oleg Shukhov
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CML-254 Asciminib Management in Chronic Myeloid Leukemia (CML) Patients With T315I Mutation
2023
·
Elena Kuzmina
, Elza Lomaia
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Pb1975: Abl1 Gene Dna Sequencing in Patients With Chronic Myeloid Leukemia and Ph+ Acute Lymphoblastic Leukemia.
2023
·
Elena Kuzmina
, Bella Biderman
, et al.
·
HemaSphere
P682: the Results of the Russian Prospective Study of Reduction and Discontinuation Treatment of Tki (readit-2020) in Chronic Myeloid Leukemia Patients With Deep Molecular Response
2023
·
Margarita Gurianova
, Oleg Shukhov
, et al.
·
HemaSphere
Results of a Single Center Survey on Vaccination Against COVID-19 in Patients with Chronic Myeloid Leukemia
2021
·
Ekaterina Yu. Chelysheva
, Anna Petrova
, et al.
·
Blood
PDF
Определение Концентрации Cd26+ Лейкозных Стволовых Клеток У Пациентов С Хроническим Миелоидным Лейкозом
2021
·
Margarita Gurianova
, Oleg Shukhov
, et al.
·
Вестник гематологии
CML-266: Second Generation Tyrosine Kinase Inhibitors in First Line Can Reduce the Time to Treatment-Free Remission in Chronic Myeloid Leukemia Patients
2020
·
Ekaterina Chelysheva
, Oleg Shukhov
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
CML-083: Prognostic Factors of Durable Treatment-Free Remission in CML Patients Based on the Prospective Study RU-SKI
2020
·
Oleg Shukhov
, Anna Petrova
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
31
Citation count:
76
H-index:
5
I10-index:
2
Year
Topic
Type